Petrus Trust Company LTA Makes New Investment in Innospec Inc. $IOSP

Petrus Trust Company LTA purchased a new position in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,839 shares of the specialty chemicals company's stock, valued at approximately $458,000.

A number of other institutional investors have also recently bought and sold shares of IOSP. NewEdge Advisors LLC boosted its holdings in shares of Innospec by 37.4% during the first quarter. NewEdge Advisors LLC now owns 4,567 shares of the specialty chemicals company's stock worth $433,000 after acquiring an additional 1,243 shares during the period. Millennium Management LLC boosted its holdings in shares of Innospec by 8,176.5% during the first quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company's stock worth $16,147,000 after acquiring an additional 168,355 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Innospec by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,833 shares of the specialty chemicals company's stock worth $1,405,000 after acquiring an additional 645 shares during the period. Hancock Whitney Corp boosted its holdings in shares of Innospec by 6.8% during the first quarter. Hancock Whitney Corp now owns 5,435 shares of the specialty chemicals company's stock worth $515,000 after acquiring an additional 347 shares during the period. Finally, Banque Transatlantique SA bought a new stake in shares of Innospec during the first quarter worth approximately $196,000. Institutional investors and hedge funds own 96.64% of the company's stock.

Innospec Stock Performance

Shares of IOSP stock traded down $0.96 during trading on Friday, hitting $82.69. The company had a trading volume of 153,476 shares, compared to its average volume of 156,941. The firm has a market capitalization of $2.05 billion, a P/E ratio of 106.01 and a beta of 1.11. The stock's 50-day moving average price is $84.34 and its 200 day moving average price is $88.13. Innospec Inc. has a one year low of $74.10 and a one year high of $128.35.

Innospec (NASDAQ:IOSP - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.09. The business had revenue of $439.70 million during the quarter, compared to analysts' expectations of $440.70 million. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The firm's revenue for the quarter was up 1.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.39 earnings per share. On average, research analysts anticipate that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Innospec from a "hold" rating to a "buy" rating in a report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat, Innospec presently has a consensus rating of "Strong Buy".

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.